Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
17
datasets available to search
ShareScore release 0.9.0
Dataset results
17 results for “BoNT-A”
A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, GripAble, in Patients With Upper Limb Spasticity Receiving Botulinum Toxin-A (BoNT-A) in the United King
ClinicalTrials.gov study NCT05169775. IPD Sharing: YES. Countries: 1. Publications: 0.
Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia
ClinicalTrials.gov study NCT00833196. IPD Sharing: Not stated. Countries: 9. Publications: 2.
Are Paraspinous Intramuscular Injections of Botulinum Toxin A (BoNT-A) Efficient in the Treatment of Chronic Low-back Pain (LBP)?
ClinicalTrials.gov study NCT03181802. IPD Sharing: NO. Countries: 1. Publications: 1.
Kinematic-based BoNT-A Bilateral Upper Limb PD Therapy
ClinicalTrials.gov study NCT02668497. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Comparative Hybrid Effects of Combining BoNT-A With Robot-assisted or Mirror Therapy for U/E Spasticity Stroke Patients
ClinicalTrials.gov study NCT02749591. IPD Sharing: NO. Countries: 1. Publications: 4.
Kinematic-based BoNT-A Injections for Bilateral ET
ClinicalTrials.gov study NCT02551848. IPD Sharing: Not stated. Countries: 1. Publications: 8.
To Document the Effectiveness of BoNT-A Injection in Adult Subjects With Upper Limb Spasticity Following Stroke
ClinicalTrials.gov study NCT01020500. IPD Sharing: Not stated. Countries: 22. Publications: 3.
Kinematic-guided BoNT-A Treatment for ET and PD Tremor
ClinicalTrials.gov study NCT02427646. IPD Sharing: Not stated. Countries: 0. Publications: 9.
Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stro
ClinicalTrials.gov study NCT05224349. IPD Sharing: YES. Countries: 1. Publications: 0.
Intradermal BoNT-A Treatment in Erythematotelangiectatic Rosacea
ClinicalTrials.gov study NCT06331533. IPD Sharing: NO. Countries: 1. Publications: 0.
A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Toxin A (BoNT-A) in Adult Patients Suffering From Upper Limb Spasticity After Stroke
ClinicalTrials.gov study NCT01239628. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)
ClinicalTrials.gov study NCT06293300. IPD Sharing: NO. Countries: 1. Publications: 0.
Integrated Management Enhances Functional Gains in Children With Cerebral Palsy Treated by BoNT-A
ClinicalTrials.gov study NCT03302871. IPD Sharing: NO. Countries: 1. Publications: 0.
Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB)
ClinicalTrials.gov study NCT06569342. IPD Sharing: NO. Countries: 1. Publications: 0.
Systems analysis of transcriptional data provides insights into muscle's biological response to botulinum toxin-A (BoNT-A)
GEO Series GSE52350. Rattus norvegicus. 20 samples. Type: Expression profiling by array.
Effect of Video Game-assisted and BoNT-A Injection Therapy on Spasticity, Activity and Participation in CP Patients
ClinicalTrials.gov study NCT04290169. IPD Sharing: NO. Countries: 0. Publications: 0.
BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm
<p>The database is related to the article “BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm”. In this database we reported all the clinical and anamnestic data of the patients who completed the trial (e.g. 32 high-frequency episodic migraine subjects and 28 of them completed the trial). After a 28-day baseline period, subjects underwent 4 subsequent onabotulinum toxin-A treatments according to the phase III research evaluating migraine prophylaxis therapy (PREEMPT) paradigm, 12-weeks apart. Onabotulinum toxin-A reduced monthly migraine days by 3.68 days. Thirty-nine percent of the patients experienced a ≥50% reduction in monthly migraine days. Onabotulinum toxin-A also reduced the number of headache days and the intake of acute medications. Disability and quality of life (QoL) scores improved markedly.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.